Immunomagnetic selection of progenitor cells from peripheral blood after thawing with an automatic system in a pediatric patient with a neuroblastoma

Transfusion

Volumn 48, Issue 3, 2008, Pages 550-552

  Zinno, Francesco ^a,b   Landi, Fabiola ^a   Aureli, Viviana ^a   Donfrancesco, Alberto ^a   Isacchi, Giancarlo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; ETOPOSIDE; THIOTEPA;

APHERESIS; ARTICLE; CASE REPORT; CD34 SELECTION; CRYOPRESERVATION; HUMAN; IMMUNOMAGNETIC SEPARATION; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; THAWING;

ANTIGENS, CD34; CHILD, PRESCHOOL; DRUG THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; NEUROBLASTOMA;

EID: 39749106715     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01569.x     Document Type: Article

References (10)

1. Prince HM, Wall D, Rischin D, Toner GC, Seymour JF, Blakey D, Haylock D, Simmons P, Wolf M, Januszewicz EH, Westerman D, Richardson G, Scarlett J, Briggs P. CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy. Cytotherapy 2002 4 : 147 55.
2. Feugier P, Bensoussan D, Girard F, Alla F, Schuhmacher A, Latger-Cannard V, Hulin C, Witz F, Witz B, Carret AS, Bordigoni P, Lederlin P, Janot C. Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells. Transfusion 2003 43 : 878 84.
3. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Malcovati L, Martinelli G, Bonfichi M, Pagnucco G, Salvaneschi L, Bernasconi C. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999 23 : 533 7.
4. Perotti CG, Del Fante C, Viarengo G, Papa P, Rocchi L, Bergamaschi P, Bellotti L, Marchesi A, Salvaneschi L. A new automated cell washer device for thawed cord blood units. Transfusion 2004 44 : 900 6.
5. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998 18 (6B 4705 8.
6. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003 65 : 1035 41.
7. Okamoto Y, Takaue Y, Saito S, Shimizu T, Suzue T, Abe T, Sato J, Hirao A, Watanabe T, Kawano Y, Kuroda Y. Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 1993 33 : 578 81.
8. Yanovich S, Mitsky P, Cornetta K, Maziarz RT, Rosenfeld C, Krause DS, Lotz JP, Bitran JD, Williams S, Preti R, Somlo G, Mills B. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial. Bone Marrow Transplant 2000 25 : 1165 74.
9. TM, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant 2003 31 : 823 8.
10. Laurenti L, Sora F, Piccirillo N, Chiusolo P, Cicconi S, Rutella S, Serafini R, Garzia MG, Leone G, Sica S. Immune reconstitution after autologous selected peripheral blood progenitor cell transplantation: comparison of two CD34+ cell-selection systems. Transfusion 2001 41 : 783 9.